Serum biomarker analysis of WJOG4107: A randomized phase II trial of adjuvant chemotherapy with S-1 versus CDDP+S-1 for resected stage II-IIIA non-small cell lung cancer (NSCLC).
Tetsuya Mitsudomi
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Yasuo Iwamoto
No relevant relationships to disclose
Shuta Tomida
No relevant relationships to disclose
Kazuko Sakai
No relevant relationships to disclose
Takeharu Yamanaka
No relevant relationships to disclose
Hirohito Tada
No relevant relationships to disclose
Hiroshige Yoshioka
No relevant relationships to disclose
Kazuya Uchino
No relevant relationships to disclose
Ichiro Yoshino
No relevant relationships to disclose
Shunichi Sugawara
No relevant relationships to disclose
Shigeki Mitsuoka
No relevant relationships to disclose
Toshiaki Takahashi
No relevant relationships to disclose
Mitsunori Ohta
No relevant relationships to disclose
Takashi Seto
Honoraria - Taiho Pharmaceutical
Research Funding - Taiho Pharmaceutical
Shinji Atagi
Honoraria - Taiho Pharmaceutical
Morihito Okada
No relevant relationships to disclose
Hideo Saka
No relevant relationships to disclose
Kazuhiko Nakagawa
No relevant relationships to disclose
Yoichi Nakanishi
No relevant relationships to disclose
Kazuto Nishio
No relevant relationships to disclose